๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study

โœ Scribed by Yaser Tajalizadekhoob; Farshad Sharifi; Hossein Fakhrzadeh; Mojde Mirarefin; Maryam Ghaderpanahi; Zohre Badamchizade; Solaleh Azimipour


Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
272 KB
Volume
261
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A multicentre, randomized, double-blind,
โœ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Efficacy of selegiline add on therapy to
โœ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOIโ€B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of